Following the cyber attack that made public the confidential medical information of dozens of Olympic athletes, including Tour de France champions and Olympic medallists Bradley Wiggins and Chris Froome, Team Sky principal David Brailsford stated this week his intent to make the team's Therapeutic Use Exemptions (TUE) "transparent" by asking riders to voluntarily allow their medical information to be made public.
The World Anti-Doping Agency (WADA) responded to this idea to Cyclingnews, firmly objecting to the disclosure of confidential medical data.
"It is a fundamental human right that personal medical information be kept confidential," the agency said in a statement. "Nobody would want such information disclosed, let alone for it to be debated publicly. Athletes should not be required to publish their TUE information, which may de facto disclose their disease or condition, nor should they be required to publicly defend their legitimate use of a TUE.
ADVERTISEMENT
"The TUE program, as it stands, is a rigorous and necessary part of elite sport; which has overwhelming acceptance from athletes, physicians and all anti-doping stakeholders."
TUEs are granted to athletes with a specific medical need to use a drug that is normally banned in competition. Froome was granted an exemption to use an oral corticosteroid in 2013 and 2014 for respiratory infection, but it is Wiggins' TUEs for an unconventional treatment of allergies with the injectable triamcinolone acetonide (Kenacort) that raised questions for Team Sky.
Unlike the TUEs of Froome, Fabian Cancellara and Jack Bobridge, all of whom had made their medical conditions known before the data breach, the case of Wiggins was exacerbated by inconsistencies such as his criticism that the UCI was not enforcing its no-needle policy and claims in his autobiography that he has never taken an injection.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2dizpNx
No comments:
Post a Comment